What MK-677 is
The discovery paper identifies L-163,191 as MK-0677, the compound commonly called MK-677 or ibutamoren. It is a non-peptide small molecule, not an amino-acid-chain peptide.
The subsequent binding study describes MK-0677 as a non-peptide spiroindoline. Distinguish compound identifiers and the chemical form of the material when comparing records; a shared abbreviated name does not establish the analytical identity of a catalogue lot.
It is listed as a laboratory reference material for in-vitro research only and is not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see the compliance page for official TGA guidance.
What the published research investigates
Patchett and colleagues measured growth-hormone release from cultured rat pituitary cells. The reported concentration-response result belongs to that functional secretion assay, not to a receptor-binding affinity experiment.
The discovery work predates molecular identification of the ghrelin receptor. Read its experimental model and endpoints in that historical context rather than treating it as a modern recombinant human-receptor study.
What native-membrane binding evidence shows
Pong and colleagues reported a high-affinity secretagogue-binding site in porcine and rat anterior-pituitary membranes. Binding was dependent on magnesium, inhibited by GTP-γ-S, and not displaced by GHRH or somatostatin in their experiments.
These findings supported a distinct G-protein-linked secretagogue receptor. They should not be relabelled as a recombinant human GHSR1a assay or a comprehensive selectivity panel across unrelated receptors.
Binding affinity and functional potency are not interchangeable
A membrane-binding experiment asks about interaction with a binding site; a secretion assay measures a downstream cellular response. Their values describe different endpoints and cannot be substituted for one another.
Species, tissue preparation, receptor expression, readout and controls all matter when comparing results. The cited animal-cell and membrane models do not establish human outcomes, and neither publication verifies the performance of a catalogue lot.
MK-677 and peptide secretagogues: compare identities, not labels
MK-677 is non-peptidic even though it appears alongside peptide secretagogues in the receptor literature. Shared research context is not structural identity, and related receptor experiments do not make different compounds interchangeable.
Use the exact compound name, chemical form and experimental endpoint when interpreting a comparison. Lot-specific identity and purity still require the actual analytical report where one is published.
Storage & handling in the lab
Aussie Peptides does not publish product- or lot-specific preparation, storage or stability data. Base preparation, storage and disposal on the supplier safety data sheet (SDS) and your institution's standard operating procedures.
Where a vial label shows a lot number and a batch report has been published for that lot, it can be looked up on the verify page and recorded alongside your experimental data.
Legal status in Australia
Materials on this site are supplied strictly for in-vitro laboratory research. They are not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see the compliance page for official TGA guidance.
Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.
Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.
Common questions
No. Secretion is a downstream functional response, while a binding experiment examines interaction with a site. Values from different endpoints or models should not be treated as interchangeable.
The cited experiments use rat pituitary cells and porcine or rat pituitary membranes. They are not a comprehensive recombinant human-receptor selectivity panel.
No. It is a non-peptide small molecule that acts at the same receptor as the peptide secretagogues, which is why it appears alongside them in the research literature.
This material is listed for in-vitro laboratory research only and is not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see our compliance page for the official TGA guidance. Purchasers must be 18 or over.
Where a batch report has been published for a given lot, it can be looked up on the verify page.
MK-677 checklist & safety notes.
A one-page laboratory checklist for MK-677: lot record-keeping, packaging inspection on arrival, and how to read a batch report where one is published. Handling and storage follow the supplier SDS and your institution's SOPs. Research use only — no human dosing protocols.
One email, no list sharing. 18+ research use only.